Ten years of finding what everyone else missed.

Most patients arrive after being told nothing is wrong despite having symptoms. This psychological injury must be addressed before therapy can succeed.

The gap between what a patient feels and what prior clinicians found is where we spend our first visits. Before any protocol begins, we need the patient to understand why their experience is real — and why it was missed.

Often, the wrong tests were run or the right tests were read through the wrong lens. The findings are usually there if you look at the right level.

We have pulled patients' existing MRIs, nerve conduction studies, and vestibular reports and found things that were documented but never acted on. The data existed. It just needed to be read by someone looking for the right thing.

Dizziness, light sensitivity, and heart rate are wired together. Splitting care across isolated specialists is why patients remain stagnant for years.

The vestibular system, the autonomic nervous system, and the visual system do not operate in silos — but most specialty care is structured as if they do. Our model is built on the assumption that you cannot reliably treat one without understanding all three.

If retests don't show change, we stop treatment. We prioritize clinical integrity over revenue to ensure patients don't waste money on false hope.

This one was hard to internalize early on. Every clinician wants to keep trying. But objective retesting every twelve visits exists precisely so that the data — not the relationship, not the hope — drives the decision to continue or stop.

It took us a full year to properly learn to read the instruments we already paid for. Buying the machine is easy; the expertise is what matters.

We have seen clinics acquire the same equipment we use and produce meaningless data because the interpretation was never learned. A number on a screen is not a finding. Knowing what that number means in the context of a specific patient's neurology — that is the work.

Every patient needs an objective baseline. We re-run instruments every twelve visits so improvement is a hard number, not a subjective feeling.

Subjective improvement is unreliable. Patients who feel better sometimes are not improving. Patients who feel stuck sometimes are. The instruments exist to cut through perception. We run them whether the patient wants to or not.

A consult should empower a patient to decide for themselves. High-pressure sales lead to patients who drop out by the fourth visit.

We track dropout rates. Patients who came in without fully understanding the model almost always leave before the work is done. The consult is not a sales call. It is informed consent. A patient who chooses to proceed with full information will finish.

A clinical plan must survive the author taking a week off. Consistency is a documentation problem, not a talent problem.

Early on, patients would describe subtle changes in their sessions depending on who was running them. We traced this back to documentation gaps — the plan existed in someone's head, not on paper. Every protocol we run today is written down in enough detail that any trained team member can execute it identically.

We prefer a simple plan the entire team can execute perfectly over an elaborate one that causes downstream stress and falls apart.

Complexity is a liability when a team of people needs to deliver a consistent experience across dozens of patients. Every unnecessary layer in a protocol is a point of failure. We strip down to the minimum that is clinically justified and build mastery of that.

Our methods today look nothing like 2016. If our protocols look the same ten years from now, something has gone wrong.

The literature keeps moving. The equipment improves. New patterns emerge in the data. Standing still in clinical practice is not neutral — it is a slow drift toward obsolescence. We build continuing education and protocol review into the calendar, not as an afterthought, but as a scheduled clinical responsibility.